Cargando…

Real-world corticosteroid use in severe pneumonia: a propensity-score-matched study

BACKGROUND: Community-acquired pneumonia (CAP) is a leading cause of morbidity and mortality worldwide despite correct antibiotic use. Corticosteroids have long been evaluated as a treatment option, but heterogeneous effects on survival have precluded their widespread implementation. We aimed to eva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ceccato, A., Russo, A., Barbeta, E., Oscanoa, P., Tiseo, G., Gabarrus, A., Di Giannatale, P., Nogas, S., Cilloniz, C., Menichetti, F., Ferrer, M., Niederman, M., Falcone, M., Torres, A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8674860/ https://www.ncbi.nlm.nih.gov/pubmed/34915895 http://dx.doi.org/10.1186/s13054-021-03840-x

Ejemplares similares

Effect of Corticosteroids on C-Reactive Protein in Patients with Severe Community-Acquired Pneumonia and High Inflammatory Response: The Effect of Lymphopenia
por: Torres, Antoni, et al.
Publicado: (2019)

Treatment with macrolides and glucocorticosteroids in severe community-acquired pneumonia: A post-hoc exploratory analysis of a randomized controlled trial
por: Ceccato, Adrian, et al.
Publicado: (2017)

Outcomes of Critically Ill Very Old Patients With Community-Acquired Pneumonia and Acute Respiratory Distress Syndrome
por: Cillóniz, Catia, et al.
Publicado: (2022)

Impact on in-hospital mortality of ceftaroline versus standard of care in community-acquired pneumonia: a propensity-matched analysis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Corticosteroids as Adjunctive Therapy in Severe Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2016)

Aspiration pneumonia
por: Niederman, Michael S., et al.
Publicado: (2022)

Early Initiation of Corticosteroids Might be Harmful in Patients Hospitalized With COVID-19 Pneumonia: A Multicenter Propensity Score Analysis
por: Pérez de Llano, Luis A., et al.
Publicado: (2022)

Lymphopenic Community Acquired Pneumonia (L-CAP), an Immunological Phenotype Associated with Higher Risk of Mortality
por: Bermejo-Martin, Jesus F., et al.
Publicado: (2017)

Impact of bronchiectasis on outcomes of hospitalized patients with acute exacerbation of chronic obstructive pulmonary disease: A propensity matched analysis
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Community-acquired Pneumonia Owing to Multidrug-Resistant Pathogens: A Step toward an Early Identification
por: Falcone, Marco, et al.
Publicado: (2021)

Lymphocytopenia as a Predictor of Mortality in Patients with ICU-Acquired Pneumonia
por: Ceccato, Adrian, et al.
Publicado: (2019)

Predictors of intensive care unit admission in patients with Legionella pneumonia: role of the time to appropriate antibiotic therapy
por: Falcone, Marco, et al.
Publicado: (2020)

Twenty-year trend in mortality among hospitalized patients with pneumococcal community-acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2018)

Corticosteroid treatment in critically ill patients with severe influenza pneumonia: a propensity score matching study
por: Moreno, Gerard, et al.
Publicado: (2018)

Antimicrobial Resistance Among Streptococcus pneumoniae
por: Cillóniz, Catia, et al.
Publicado: (2018)

Severe community-acquired pneumonia: Characteristics and prognostic factors in ventilated and non-ventilated patients
por: Ferrer, Miquel, et al.
Publicado: (2018)

Community-acquired polymicrobial pneumonia in the intensive care unit: aetiology and prognosis
por: Cillóniz, Catia, et al.
Publicado: (2011)

Pulmonary Aspergillosis: An Evolving Challenge for Diagnosis and Treatment
por: Russo, Alessandro, et al.
Publicado: (2020)

Clinical variables predicting the risk of a hospital stay for longer than 7 days in patients with severe acute exacerbations of chronic obstructive pulmonary disease: a prospective study
por: Crisafulli, Ernesto, et al.
Publicado: (2018)

Time to blood culture positivity as a predictor of clinical outcomes and severity in adults with bacteremic pneumococcal pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2017)

Lymphopenia Is Associated With Poor Outcomes of Patients With Community-Acquired Pneumonia and Sepsis
por: Cilloniz, Catia, et al.
Publicado: (2021)

Characteristics and Outcomes in Patients with Ventilator-Associated Pneumonia Who Do or Do Not Develop Acute Respiratory Distress Syndrome. An Observational Study
por: Barbeta, Enric, et al.
Publicado: (2020)

Bacterial co-infection with H1N1 infection in patients admitted with community acquired pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2012)

Management of COVID patients with convalescent plasma: Do we have the final word?
por: Menichetti, Francesco, et al.
Publicado: (2022)

Risk and Prognostic Factors in Very Old Patients with Sepsis Secondary to Community-Acquired Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Adjuvant therapies in critical care: steroids in community-acquired pneumonia
por: Torres, Antoni, et al.
Publicado: (2017)

Impact of Cardiovascular Failure in Intensive Care Unit-Acquired Pneumonia: A Single-Center, Prospective Study
por: Martin-Loeches, Ignacio, et al.
Publicado: (2021)

Impact of Cefotaxime Non-susceptibility on the Clinical Outcomes of Bacteremic Pneumococcal Pneumonia
por: Cillóniz, Catia, et al.
Publicado: (2019)

Extremely drug-resistant NDM-9-producing ST147 Klebsiella pneumoniae causing infections in Italy, May 2020
por: Falcone, Marco, et al.
Publicado: (2020)

Microorganisms resistant to conventional antimicrobials in acute exacerbations of chronic obstructive pulmonary disease
por: Estirado, Cristina, et al.
Publicado: (2018)

Corticosteroids Treatment of Patients with Coronavirus Disease 2019: A Propensity Score Matching Study
por: Liang, Meng-yuan, et al.
Publicado: (2021)

Time to appropriate antibiotic therapy is a predictor of outcome in patients with bloodstream infection caused by KPC-producing Klebsiella pneumoniae
por: Falcone, Marco, et al.
Publicado: (2020)

Risk factors and outcomes of ventilator-associated pneumonia in COVID-19 patients: a propensity score matched analysis
por: Martínez-Martínez, María, et al.
Publicado: (2021)

Meropenem-Vaborbactam as Salvage Therapy for Ceftazidime-Avibactam-, Cefiderocol-Resistant ST-512 Klebsiella pneumoniae–Producing KPC-31, a D179Y Variant of KPC-3
por: Tiseo, Giusy, et al.
Publicado: (2021)

What’s new in severe community-acquired pneumonia? Corticosteroids as adjunctive treatment to antibiotics
por: Torres, Antoni, et al.
Publicado: (2015)

Budesonide versus systemic corticosteroids in IgA Nephropathy: A retrospective, propensity-matched comparison
por: Ismail, Gener, et al.
Publicado: (2020)

Efficacy of treatment with corticosteroids for fibrotic hypersensitivity pneumonitis: a propensity score-matched cohort analysis
por: Ejima, Masaru, et al.
Publicado: (2021)

Remdesivir and survival outcomes in critically ill patients with COVID-19: A multicentre observational cohort study
por: Cillóniz, Catia, et al.
Publicado: (2023)

An evaluation of exact matching and propensity score methods as applied in a comparative effectiveness study of inhaled corticosteroids in asthma
por: Burden, Anne, et al.
Publicado: (2017)

Multidrug Resistant Gram-Negative Bacteria in Community-Acquired Pneumonia
por: Cillóniz, C., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e1cv6gedfopgvdrjbh9dbha1vq